Intuitive Surgical (ISRG) Reports Q2 Earnings: What Key Metrics Have to Say

23.07.25 00:00 Uhr

Werte in diesem Artikel
Aktien

434,05 EUR -1,85 EUR -0,42%

76,50 EUR 0,00 EUR 0,00%

Indizes

PKT PKT

23.063,6 PKT -116,5 PKT -0,50%

20.892,7 PKT -81,5 PKT -0,39%

6.309,6 PKT 4,0 PKT 0,06%

Intuitive Surgical, Inc. (ISRG) reported $2.44 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 21.4%. EPS of $2.19 for the same period compares to $1.78 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $2.35 billion, representing a surprise of +3.93%. The company delivered an EPS surprise of +14.06%, with the consensus EPS estimate being $1.92.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Intuitive Surgical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Da Vinci Surgical System Installed Base: 10,488 versus the four-analyst average estimate of 10,427.Revenue- Product (Instruments and accessories and Systems): $2.05 billion compared to the $1.96 billion average estimate based on seven analysts. The reported number represents a change of +21% year over year.Revenue- Services: $391.2 million versus $368.86 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +23.3% change.Revenue- Systems: $574.7 million versus $516.21 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +28.2% change.Revenue- Instruments and accessories: $1.47 billion versus $1.44 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +18.5% change.View all Key Company Metrics for Intuitive Surgical here>>>Shares of Intuitive Surgical have returned +0.2% over the past month versus the Zacks S&P 500 composite's +5.9% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Intuitive Surgical und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Intuitive Surgical

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Intuitive Surgical Inc

Wer­bung

Analysen zu Intuitive Surgical Inc

DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
26.01.2018Intuitive Surgical HoldCanaccord Adams
18.07.2017Intuitive Surgical Sector PerformRBC Capital Markets
30.06.2017Intuitive Surgical NeutralCantor Fitzgerald
30.05.2017Intuitive Surgical HoldCanaccord Adams
17.04.2017Intuitive Surgical Sector PerformRBC Capital Markets
DatumRatingAnalyst
23.01.2015Intuitive Surgical SellCRT Capital
22.10.2014Intuitive Surgical SellCRT Capital
09.01.2009Intuitive Surgical DowngradeBrean Murray, Carret & Co., LLC
26.08.2005Update Intuitive Surgical Inc. : UnderperformJefferies & Co

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen